During the past decade, University of Calgary, Foothills Medical Centre conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 12 clinical trials were completed, i.e. on average, 38.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 8 clinical trials were completed. i.e. 61.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Calgary, Foothills Medical Centre" #1 sponsor was "University of Calgary" with 8 trials, followed by "Pfizer" with 6 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 5 trials sponsored, "Dr. Michael Hill" with 2 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Calgary, Foothills Medical Centre" #1 collaborator was "University of Calgary" with 7 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 3 trials as a collaborator and "Medical University of South Carolina" with 3 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 63 trials.

According to Clinical.Site data, the most researched conditions in "University of Calgary, Foothills Medical Centre" are "Cystic Fibrosis" (5 trials), "Cardiovascular Disease" (3 trials), "Stroke" (3 trials), "Stroke, Acute" (3 trials) and "Acute Ischemic Stroke" (2 trials). Many other conditions were trialed in "University of Calgary, Foothills Medical Centre" in a lesser frequency.

Most popular intervention types in "University of Calgary, Foothills Medical Centre" are "Drug" (34 trials), "Device" (7 trials), "Biological" (6 trials), "Other" (6 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "IVA" (5 trials), "ELX/TEZ/IVA" (3 trials), "Apixaban" (2 trials) and "Tafamidis" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Calgary, Foothills Medical Centre" are 52 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University of Calgary, Foothills Medical Centre". undefined are not yet recruiting, 8 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in University of Calgary, Foothills Medical Centre, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in University of Calgary, Foothills Medical Centre, 2 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".